WeVote

Bill

WeVote Research Nonpartisan
Bill Summary · SB 121

Legislative bill overview

SB 121 proposes amendments to Utah's medical cannabis program, though the specific legislative language is not provided in the available information. The bill has advanced through the Senate Health and Human Services Committee with a favorable recommendation as of January 2026 and is currently positioned for second reading consideration in the full Senate.

Why is this important

Medical cannabis policy directly affects patient access to treatment options, healthcare provider authority, and state regulatory frameworks. Utah has maintained one of the nation's more restrictive cannabis policies, so modifications to the medical program could significantly impact eligible patients and healthcare practitioners seeking to participate in the program.

Potential points of contention

  • Patient access expansion vs. public health concerns: Amendments may broaden eligibility criteria or qualifying conditions, raising questions about program oversight and potential misuse
  • Provider participation and liability: Changes could affect which healthcare professionals can recommend cannabis and associated legal protections or liabilities
  • Regulatory implementation costs: Expanded programs require funding for enforcement, testing standards, and administrative infrastructure

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.